Progressive familial intrahepatic cholestasis (PFIC or Byler disease) is a rare autosomal recessive form of severe and fatal cholestatic liver disease. A locus for PFIC has recendy been mapped to chromosome 18q21-q22 in the original Byler pedigree. This region harbours the locus for a related phenotype, benign recurrent intrahepatic cholestasis (BRIC), suggesting that these traits are allelic. Linkage analysis was undertaken in five consanguineous PFIC pedigrees from Saudi Arabia using marker loci (D18S69, D18S41, D18S64, D18S38, D18S42, D18S55, D18S68, and D18S61) which span the Byler disease/BRIC region on 18q21-q22. In this family set the disease locus was excluded from this region, showing that locus heterogeneity exists for the PFIC phenotype. (JMed Genet 1996;33:833-836) 
There are a number of separate identifiable cholestatic diseases with onset in childhood, some of which have obvious mendelian inheritance. Some are clearly syndromic, with non-hepatic manifestations, such as Alagille and Aagenaes syndromes. Others have characteristic histological or biochemical features. Progressive familial intrahepatic cholestasis (PFIC or Byler disease, OMIM 211600) is an example of the latter. PFIC was first described in a large Amish pedigree' and patients with the same disease phenotype have now been described in many populations.2 Inheritance is autosomal recessive with a high incidence of parental consanguinity. Despite the fact that the term PFIC has been applied to a variety of familial cholestatic phenotypes,3 the patients used in this research and the discussion thereof are restricted to the phenotype corresponding to that seen in the original Byler family.
The disease presents in the first few months of life with intense pruritis, jaundice, malabsorption, loose stools, and failure to thrive. A number of characteristic features distinguish PFIC from other cholestatic diseases. Initially there appears to be a relapsing course, with clearing of jaundice between episodes, but progression occurs to severe persistent cholestasis and biliary cirrhosis. The episodic jaundice is associated with a marked rise of serum bile acids and depression of biliary bile acids4 and these changes become persistent. The most unusual and striking feature of these children is that neither the serum cholesterol nor the y-glutamyl transpeptidase (yGT) are raised.5 These findings in particular differentiate PFIC from other cholestatic diseases, as bile is the only route of cholesterol excretion, and yGT is released from the biliary epithelium by any damage, particularly by bile acids. Liver biopsy shows marked intrahepatic cholestasis with progressive fibrosis. Death usually occurs in the first or early in the second decade of life.
Benign recurrent intrahepatic cholestasis (BRIC, OMIM 243300) is a similar but phenotypically quite distinct condition. BRIC patients also have intermittent cholestasis and jaundice but remain otherwise well and there is no progression to chronic liver disease. A BRIC locus has been mapped to chromosome 18q21-22 in an isolated Dutch population with a presumed founder mutation.6 Subsequently, in members of the original Byler family, a locus for PFIC has been mapped to the same chromosomal region.7 It is assumed that the causative gene will be involved in bile acid transport within the liver, but no plausible candidate genes have yet been identified in this region of chromosome 18.
Linkage analysis was undertaken in five unrelated consanguineous Saudi Arabian families segregating PFIC, using marker loci spanning the region of chromosome 18 to which BRIC and PFIC have been mapped. No regions of homozygosity were seen in any of the affected people, and negative lod scores across the region were obtained in all families. This provides unequivocal evidence for locus heterogeneity in PFIC.
Materials and methods

SUBJECTS
Six affected children from five first cousin marriages, their parents, and a total of 12 unaffected sibs were analysed (fig 1) . Six further children from family 4 are known to have already died from severe cholestatic liver disease. The five families are not known to be related. The affected subjects all have jaundice with onset in the first three months of life, pruritis with maximum age of onset of 7 months, and severe failure to thrive. All the affected children have biochemical and histological evidence of marked cholestasis, with very raised serum bile acid concentrations, low or normal cholesterol levels, and normal yGT levels (table 1). They all have liver biopsy appearances of severe intrahepatic cholestasis and cirrhosis. Vertical scale shows location lod score. The PFIC locus previously described is shown above the axis, as defined by limiting recombinants.7 The sex averaged distances in cM between loci are D18S69-2-D18S41-5-D18S64-3-D18S38-7.5-D18S42-1-D18S55-1-D18S68-9-D18S61. 
Results
No significant common regions of homozygosity were identified (fig 1) . At all the marker loci examined, with the exception of D18S42, at least one person was homozygous. In seven of the 11 such loci the parents were also homozygous, rendering the corresponding meioses uninformative. Both children in family 5 were homozygous at D18S64 as was one parent. In family 5, the homozygosity seen at D18S68 and D18S61 is not common to both patients indicating obligate recombinants. The statistical significance of these results can be represented as a multipoint lod score. The individual family multipoint lod scores were consistently negative over the whole region examined, though as each family is small no one family achieved a region of exclusion (defined as a lod score of less than -2) of more than a few centimorgans. However, the maximum total lod score assuming locus homogeneity was -4.3 over the genetic interval defined by D18S69 and D18S61 (fig 2) . The unlikely possibility that each family has acquired a second disease allele by marriage can be allowed for by increasing the disease allele frequency to 0.10. Under this model the maximum lod score over this region is -2.9.
Discussion
The absence of homozygosity in a set of closely linked markers has entirely excluded the PFIC/ BRIC locus on chromosome 18 in these families, assuming inheritance of two copies of a disease gene from a great grandparent. The only other mechanism which needs to be considered is that all the families have acquired a disease allele by marriage to an unrelated person. Even this possibility can be excluded by the observation of obligate recombinants within the region.
The patients used in this study are phenotypically indistinguishable from the affected subjects in the Byler family. Although the mapping of the PFIC locus involved only two affected subjects, a large number of ancestral meioses were examined in the analysis.7 Therefore the likelihood of the observed common segments being inherited by chance, and therefore not containing the disease gene, was 1 in 1 x 105. We have excluded this region of 18q in our families. These new data therefore show locus heterogeneity.
The biochemical features of PFIC suggest a defect in the transport of bile acids from blood to bile. Bile acids are synthesised by hepatocytes and are actively excreted in bile. Ninety percent of the bile acid content of bile is reabsorbed in the small intestine and enters the portal circulation. In normal people uptake of bile acids by hepatocytes achieves a first pass clearance of 80-90%. Under normal circumstances they are therefore subject to an efficient enterohepatic circulation. As a result total serum bile acids are normally maintained at less than 10 .imol/l in peripheral blood. To achieve this there are highly efficient bile acid uptake mechanisms on the basolateral surface of hepatocytes. 
